Frank Dobson, before he relinquished the position of Secretary of State for Health, finally pronounced on Relenza and gave it the thumbs-down, at least for the present. According to the Times, further clinical trials are to be carried out, this time with patients in the "at risk" groups, before the drug will be considered for National Health Service usage. For all his supposed faults, big Frank has at least stuck to his guns over this issue.
展开▼
